Italy
BiomimX® Srl is an innovative biotech startup originating from a collaboration with the Politecnico di Milano. The company strives to advance drug screening methodologies by developing beating organs-on-chip platforms, thereby aligning with its slogan, "Mimic human complexity in a Beat".
Founded in 2017 and headquartered in Italy, BiomimX® stands out in the field of bioengineering by creating three-dimensional, functional miniaturized organs. Their flagship products include uBeat, a human heart-on-chip, and uKnee, which simulates a human osteoarthritic joint. These platforms enable high-throughput testing of drug toxicity and functionality, providing a cutting-edge solution for pharmaceutical testing.
The company recently secured a €1.50M grant from the European Commission as of November 2024, spotlighting trust in its technological potential and innovative direction. This investment underscores BiomimX® Srl's capability to advance research and development in the biotech sector.
